Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-12

Clinical Trial Update: Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating cetuximab combined with hepatic artery infusion chemotherapy to treat liver metastases in metastatic colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)

Snippet

Sponsor: Association pour la Recherche sur le Temps Biologique et la Chronothérapie | Conditions: Metastatic Colorectal Cancer, Liver Metastases | Phase 2 | Status: UNKNOWN